This week in MedTech, capital is flowing into technologies that redefine intervention and precision in treatment. New funding and major deals across vascular innovation, AI imaging, orthopedic solutions, surgical robotics, and organ care signal strong momentum for devices that improve outcomes through smarter design and data-driven insight. Read more below.
Terumo completes $1.5B acquisition of OrganOx
OrganOx announced the completion of its acquisition by Terumo in a deal valued at approximately $1.5 billion. The now-completed deal makes OrganOx a wholly owned subsidiary of Terumo.
Terumo already had an interest prior to the acquisition, with its Terumo Ventures arm taking part in a $142 million fundraising round in March.
CEO Hikaru Samejima
Last week’s tracker: CoMind, Onward & more
VentureMed Group closes $28M Series C funding
The company announced the closing of a $28 million Series C financing round led by S3 Ventures, and joined by existing investors including Endeavour Vision.
In addition to expanded commercial infrastructure, the funding will also advance VentureMed’s clinical program and support new product development, including new applications in adjacent vascular settings.
President and CEO Denis Harrington
Optiscan Imaging secures $17.75M to propel medical device innovation
The funds will support clinical studies, testing, and certifications necessary for US FDA premarket approval, as well as the development of next-generation technology.
The company has begun a breast cancer study and is planning comprehensive commercialization strategies to maximize the potential of its devices. This strategic move is expected to strengthen its market position and drive innovation in the healthcare industry.
CEO Camile Farah
Spectral AI raises $7.6m additional growth capital for its DeepView System
The offering will provide the company with additional growth capital for the continued expansion and development of its DeepView System.
The transaction includes the issuance of 4,000,000 shares of its common stock and pre-funded warrants at a price of $1.90 per share and corresponding warrants with an exercise price of $2.51 per share of common stock.
Chairman of the board J. Michael DiMaio
Antegrade Medical announces the closing of a $7.3M seed financing
This financing will support the development of minimally invasive instruments for interventional cardiology procedures.
It was led by Sectoral Asset Management through its Fonds Medtech Ventures. In addition, Genesys Capital, Desjardins Capital through the Desjardins Regional and Cooperative fund, Seido Capital, and private investors also participated in this first financing round.
President and CEO Louis Laflamme
CustoMED raised $6M to scale AI 3D printed solutions for orthopedic surgery
CustoMED, a pioneer in AI-driven, surgeon-first platforms for patient-specific orthopedic solutions, announced the successful completion of its seed round, bringing total funding to $6 million.
The round includes investment from Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, a leading orthopedic implant company, and Avishai Abrahami, Co-founder and CEO of Wix.
Co-founder Or Benifla
Surgical Automations closed $3.4M seed round
The company announced that it closed a $3.4 million oversubscribed seed funding round to support its surgical robotics platform.
Dr. Fred Moll, cofounder of Intuitive Surgical, and TurboStart co-led the round. The company aims to leverage AI and automation to “transform gastrointestinal endoscopy.”
Founder and CEO Sanket Chauhan
Polyembo closes funding to commercialize new vascular embolic technology
Polyembo, a privately held medical device company founded to develop the Scrunchy, Sphere, PuffyCoil, and other vascular embolization technologies, announced they closed a new round of funding.
Funding was led by multinational strategic investor and will be used to advance innovative product development and regulatory clearances.
Chief Executive-Senior Advisor John Crowley
